ES2963508T3 - Derivados de 5-hidroxi-7-oxabiciclo[2.2.1]heptano-2-carboxamida para inducir condrogénesis para el tratamiento del daño articular - Google Patents

Derivados de 5-hidroxi-7-oxabiciclo[2.2.1]heptano-2-carboxamida para inducir condrogénesis para el tratamiento del daño articular Download PDF

Info

Publication number
ES2963508T3
ES2963508T3 ES19821288T ES19821288T ES2963508T3 ES 2963508 T3 ES2963508 T3 ES 2963508T3 ES 19821288 T ES19821288 T ES 19821288T ES 19821288 T ES19821288 T ES 19821288T ES 2963508 T3 ES2963508 T3 ES 2963508T3
Authority
ES
Spain
Prior art keywords
trifluoromethyl
hydroxy
carboxamide
rac
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19821288T
Other languages
English (en)
Spanish (es)
Inventor
James Paul Lajiness
Andrew Valiere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2963508T3 publication Critical patent/ES2963508T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES19821288T 2018-12-06 2019-12-04 Derivados de 5-hidroxi-7-oxabiciclo[2.2.1]heptano-2-carboxamida para inducir condrogénesis para el tratamiento del daño articular Active ES2963508T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862776267P 2018-12-06 2018-12-06
PCT/IB2019/060454 WO2020115683A1 (en) 2018-12-06 2019-12-04 5-hydroxy-7-oxabicyclo[2.2.1]heptane-2-carboxamide derivatives for inducing chondrogenesis for treating joint damage

Publications (1)

Publication Number Publication Date
ES2963508T3 true ES2963508T3 (es) 2024-03-27

Family

ID=68916501

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19821288T Active ES2963508T3 (es) 2018-12-06 2019-12-04 Derivados de 5-hidroxi-7-oxabiciclo[2.2.1]heptano-2-carboxamida para inducir condrogénesis para el tratamiento del daño articular

Country Status (6)

Country Link
US (1) US12257243B2 (cg-RX-API-DMAC7.html)
EP (1) EP3891154B1 (cg-RX-API-DMAC7.html)
JP (1) JP7471291B2 (cg-RX-API-DMAC7.html)
CN (1) CN113015735B (cg-RX-API-DMAC7.html)
ES (1) ES2963508T3 (cg-RX-API-DMAC7.html)
WO (1) WO2020115683A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2963508T3 (es) 2018-12-06 2024-03-27 Novartis Ag Derivados de 5-hidroxi-7-oxabiciclo[2.2.1]heptano-2-carboxamida para inducir condrogénesis para el tratamiento del daño articular
WO2020115684A1 (en) * 2018-12-06 2020-06-11 Novartis Ag 6-hydroxy-8-oxatricyclo[3.2.1.02,4]octane-2-carboxamide derivatives for inducing chondrogenesis for treating joint damage

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732484B2 (en) 2000-08-01 2010-06-08 University Of Virginia Patent Foundation Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
WO2007130353A2 (en) 2006-05-01 2007-11-15 Johns Hopkins University Phase 2 inducers, ppar-alpha agonists and related signalling pathways protect cartilage against inflammation, apoptosis and stress
PE20160507A1 (es) 2009-07-14 2016-05-20 Scripps Research Inst Diferenciacion de celulas madre mesenquimales
WO2012129562A2 (en) 2011-03-24 2012-09-27 The Scripps Research Institute Compounds and methods for inducing chondrogenesis
HRP20241236T1 (hr) * 2014-05-13 2024-12-06 Novartis Ag Spojevi i pripravci za induciranje hondrogeneze
US9745253B2 (en) 2015-03-13 2017-08-29 Forma Therapeutics, Inc. Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
UY37759A (es) * 2017-06-09 2019-01-31 Novartis Ag Compuestos y composiciones para inducir condrogénesis
EP3706710B1 (en) 2017-11-10 2024-04-10 Novartis AG Extended release formulations for intra-articular applications
ES2963508T3 (es) 2018-12-06 2024-03-27 Novartis Ag Derivados de 5-hidroxi-7-oxabiciclo[2.2.1]heptano-2-carboxamida para inducir condrogénesis para el tratamiento del daño articular

Also Published As

Publication number Publication date
CN113015735A (zh) 2021-06-22
US12257243B2 (en) 2025-03-25
US20220071972A1 (en) 2022-03-10
JP2022509765A (ja) 2022-01-24
EP3891154B1 (en) 2023-08-16
WO2020115683A1 (en) 2020-06-11
JP7471291B2 (ja) 2024-04-19
CN113015735B (zh) 2024-06-21
EP3891154A1 (en) 2021-10-13

Similar Documents

Publication Publication Date Title
AU2020343671B2 (en) RIP1 inhibitory compounds and methods for making and using the same
CN112312904B (zh) 螺环化合物
ES2940911T3 (es) Compuestos de 2,4-diamino-pirimidina y su uso como inhibidores de IRAK4
BR112021013924A2 (pt) Inibidores de pcsk9 e métodos de uso do mesmo
JP2024054409A (ja) 心筋サルコメア阻害剤
BR112014030577B1 (pt) Dihidronaftiridinas e compostos relacionados, bem como composições farmacêuticas compreendendo os mesmos
JP2017537948A (ja) Nadphオキシダーゼ阻害剤としてのアミドチアジアゾール誘導体
US20150329530A1 (en) Antibacterial compunds
WO2017023941A1 (en) Benzazole compounds and methods for making and using the compounds
US12209096B2 (en) Compounds and compositions for inducing chondrogenesis
CN119504808A (zh) 化合物、其制备方法及用途
CN113015735B (zh) 用于诱导软骨发生以治疗关节损害的5-羟基-7-氧杂双环[2.2.1]庚烷-2-甲酰胺衍生物
ES2972813T3 (es) Derivados de 4-fluoro-1H-pirazolo[3,4-c]piridina como inhibidores selectivos de la tirosina quinasa de Bruton (BTK) para el tratamiento de linfoma de células B y enfermedades autoinmunitarias
ES2965684T3 (es) Derivados de 6-hidroxi-8-oxatriciclo[3.2.1.02,4]octano-2-carboxamida para inducir condrogénesis para el tratamiento del daño articular
CN118339149A (zh) 用于治疗与lpa受体活性相关的病症的化合物和组合物
CA3256954A1 (en) Inhibitors of Human Respiratory Syncytial Virus and Human Metapneumovirus
HK40096806A (en) Compounds and compositions for inducing chondrogenesis
HK40055222B (en) Compounds and compositions for inducing chondrogenesis
HK40055222A (en) Compounds and compositions for inducing chondrogenesis
HK40067957A (en) Thienopyrimidine derivatives as lpa receptor 2 inhibitors